ATE360001T1 - 4-aryl-4-(naphth-1-ylmethylamino)methyl-piperid n-verbindungen und deren verwendung - Google Patents

4-aryl-4-(naphth-1-ylmethylamino)methyl-piperid n-verbindungen und deren verwendung

Info

Publication number
ATE360001T1
ATE360001T1 AT03768468T AT03768468T ATE360001T1 AT E360001 T1 ATE360001 T1 AT E360001T1 AT 03768468 T AT03768468 T AT 03768468T AT 03768468 T AT03768468 T AT 03768468T AT E360001 T1 ATE360001 T1 AT E360001T1
Authority
AT
Austria
Prior art keywords
sub
compounds
piperide
ylmethylamino
naphth
Prior art date
Application number
AT03768468T
Other languages
English (en)
Inventor
Peter Bernstein
Paul Warwick
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE360001T1 publication Critical patent/ATE360001T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03768468T 2002-12-20 2003-12-18 4-aryl-4-(naphth-1-ylmethylamino)methyl-piperid n-verbindungen und deren verwendung ATE360001T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43513002P 2002-12-20 2002-12-20

Publications (1)

Publication Number Publication Date
ATE360001T1 true ATE360001T1 (de) 2007-05-15

Family

ID=32682165

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03768468T ATE360001T1 (de) 2002-12-20 2003-12-18 4-aryl-4-(naphth-1-ylmethylamino)methyl-piperid n-verbindungen und deren verwendung

Country Status (8)

Country Link
US (1) US20060058352A1 (de)
EP (1) EP1581495B1 (de)
JP (1) JP2006512363A (de)
AT (1) ATE360001T1 (de)
AU (1) AU2003291589A1 (de)
DE (1) DE60313365T2 (de)
ES (1) ES2286470T3 (de)
WO (1) WO2004056771A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1546101A1 (de) * 2002-09-09 2005-06-29 AstraZeneca AB Naphthyletherverbindungen und deren verwendung
EP1679069A4 (de) * 2003-10-21 2009-05-13 Dainippon Sumitomo Pharma Co Neues piperidinderivat
GB0412865D0 (en) 2004-06-09 2004-07-14 Glaxo Group Ltd Chemical compounds
US7494986B2 (en) 2004-07-20 2009-02-24 Bristol-Myers Squibb Company Cycloalkylamine derivatives as NK-1/SSRI antagonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3693820A (en) * 1971-06-03 1972-09-26 Robert P Linkletter Safety closure cap
US3931891A (en) * 1974-10-11 1976-01-13 Peppler Stanley R K Pill container with pocket
FR2603871B1 (fr) * 1986-09-16 1988-12-02 Morel Simone Capsule de securite formant bouchon pour flacons et objets analogues
GB9601960D0 (en) * 1996-01-31 1996-04-03 Galton Fenzi Miles D M Containers
US5908125A (en) * 1997-04-16 1999-06-01 Weatherchem Corporation Child-resistant screw-on cap and bottle
US6365602B1 (en) * 1998-07-10 2002-04-02 Astra Zeneca Ab N-substituted naphthalene carboxamides as neurokinin-receptor antagonists
GB9907571D0 (en) * 1999-04-06 1999-05-26 Zeneca Ltd Compounds
ATE416162T1 (de) * 2002-08-29 2008-12-15 Astrazeneca Ab Naphthamidderivate und deren verwendung

Also Published As

Publication number Publication date
DE60313365T2 (de) 2007-12-27
ES2286470T3 (es) 2007-12-01
JP2006512363A (ja) 2006-04-13
AU2003291589A1 (en) 2004-07-14
DE60313365D1 (de) 2007-05-31
WO2004056771A1 (en) 2004-07-08
EP1581495A1 (de) 2005-10-05
EP1581495B1 (de) 2007-04-18
US20060058352A1 (en) 2006-03-16

Similar Documents

Publication Publication Date Title
SE0104251D0 (sv) Novel compounds
CY1115925T1 (el) Παραγωγα πυριδαζινονης
NO20044995L (no) Heterosykliske forbindelser
DE60334536D1 (de) Furylverbindungen
SE0401971D0 (sv) Piperidne derivatives
GEP20084367B (en) Diazepinoindole derivatives as kinase inhibitors
CY1114574T1 (el) Παραγωγα πιπεριδινης και πιπεραζινης για τη θεραπεια ογκων
ATE477256T1 (de) Thienylverbindungen
CY1112031T1 (el) Υποκατεστημενη 5-φαινυλο-3,6-διυδρο-2-οξο-6η-[1,3,4]θειαδιαζινη
CY1105047T1 (el) Ενωσεις πυριδοπυριμιδινονης, η μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις που τις περιεχουν
GB0314967D0 (en) Piperazine derivatives
SE0401969D0 (sv) Piperidine derivatives
ATE331711T1 (de) Entzündungshemmende 3-arylthio-3- thiazolylalkylamine
SE0203302D0 (sv) Novel Compounds
NO20080133L (no) Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer
WO2004041802A8 (en) 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
SE0300105D0 (sv) Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
ATE360001T1 (de) 4-aryl-4-(naphth-1-ylmethylamino)methyl-piperid n-verbindungen und deren verwendung
ATE416162T1 (de) Naphthamidderivate und deren verwendung
SE0400027D0 (sv) Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
CY1106472T1 (el) Η χρηση των παραγωγων υδροξυπυριδονης στην επουλωση πληγων
BR0308870A (pt) Composto, composição farmacêutica, processo para preparar um composto, uso de um composto, e método para tratar um distúrbio trombótico em um paciente
NO20053805L (no) Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav
SE0300907D0 (sv) Novel compounds
NO20045437L (no) Medikamenter for behandling av akutte dysfunksjoner i portavenesirkulasjon og hepatisk sirkulasjon

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties